These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9924453)

  • 1. Estimation of the past and future burden of mortality from mesothelioma in France.
    Ilg AG; Bignon J; Valleron AJ
    Occup Environ Med; 1998 Nov; 55(11):760-5. PubMed ID: 9924453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of predictions of mortality from pleural mesothelioma in the Netherlands.
    Segura O; Burdorf A; Looman C
    Occup Environ Med; 2003 Jan; 60(1):50-5. PubMed ID: 12499457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuing increase in mesothelioma mortality in Britain.
    Peto J; Hodgson JT; Matthews FE; Jones JR
    Lancet; 1995 Mar; 345(8949):535-9. PubMed ID: 7776771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future trends in mortality of French men from mesothelioma.
    Banaei A; Auvert B; Goldberg M; Gueguen A; Luce D; Goldberg S
    Occup Environ Med; 2000 Jul; 57(7):488-94. PubMed ID: 10854503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models.
    Marinaccio A; Montanaro F; Mastrantonio M; Uccelli R; Altavista P; Nesti M; Costantini AS; Gorini G
    Int J Cancer; 2005 May; 115(1):142-7. PubMed ID: 15645436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European mesothelioma epidemic.
    Peto J; Decarli A; La Vecchia C; Levi F; Negri E
    Br J Cancer; 1999 Feb; 79(3-4):666-72. PubMed ID: 10027347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trends in mortality from primary pleural tumor and incidence of pleural mesothelioma in Italy: a particularly serious situation].
    Merler E; Lagazio C; Biggeri A
    Epidemiol Prev; 1999; 23(4):316-26. PubMed ID: 10730473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model.
    Murayama T; Takahashi K; Natori Y; Kurumatani N
    Am J Ind Med; 2006 Jan; 49(1):1-7. PubMed ID: 16362942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.
    Oddone E; Bollon J; Nava CR; Bugani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia.
    Reid A; Berry G; Heyworth J; de Klerk NH; Musk AW
    Occup Environ Med; 2009 Mar; 66(3):169-74. PubMed ID: 18805882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050.
    Hodgson JT; McElvenny DM; Darnton AJ; Price MJ; Peto J
    Br J Cancer; 2005 Feb; 92(3):587-93. PubMed ID: 15668716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil.
    Algranti E; Saito CA; Carneiro AP; Moreira B; Mendonça EM; Bussacos MA
    Cancer Epidemiol; 2015 Oct; 39(5):687-92. PubMed ID: 26320384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Future increase of the incidence of mesothelioma due to occupational exposure to asbestos in the past].
    Burdorf A; Barendregt JJ; Swuste PH; Heederik DJ
    Ned Tijdschr Geneeskd; 1997 May; 141(22):1093-8. PubMed ID: 9380136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer modeling of population exposure to a carcinogen: the example of asbestos and mesothelioma mortality in France.
    Banaei A; Auvert B; Goldberg M
    Comput Biomed Res; 2000 Apr; 33(2):97-109. PubMed ID: 10854118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asbestosis and mesothelioma among British asbestos workers (1971-2005).
    Harding AH; Darnton AJ
    Am J Ind Med; 2010 Nov; 53(11):1070-80. PubMed ID: 20957726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Hodgson JT; Darnton A
    Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of mesothelioma from exposure to crocidolite asbestos: a 1995 update of a South African mortality study.
    Kielkowski D; Nelson G; Rees D
    Occup Environ Med; 2000 Aug; 57(8):563-7. PubMed ID: 10896964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple benchmark for mesothelioma projection for Great Britain.
    Martínez-Miranda MD; Nielsen B; Nielsen JP
    Occup Environ Med; 2016 Aug; 73(8):561-3. PubMed ID: 27245376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1891-1920 birth cohort of Quebec chrysotile miners and millers: mortality 1976-88.
    McDonald JC; Liddell FD; Dufresne A; McDonald AD
    Br J Ind Med; 1993 Dec; 50(12):1073-81. PubMed ID: 8280638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.